Raggruppamento Secondario: Atrofia Muscolare Spinale (SMA)

Filtra

Data

The Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): test development and reliability

Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric study

The Hammersmith functional score correlates with the SMN2 copy number: a multicentric study

Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy

Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3

Bulbar function in spinal muscular atrophy (SMA): State of art and new challenges. 21st July 2023, Rome, Italy

Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome?

Therapeutic Role of Nusinersen on Respiratory Progression in Pediatric Patients With Spinal Muscular Atrophy Type 2 and Nonambulant Type 3

Changes in abilities over the initial 12 months of nusinersen treatment for type II SMA.

Effectiveness of Nusinersen in Adolescents and Adults with Spinal Muscular Atrophy: Systematic Review and Meta-analysis

Torna in alto